TP53 and cervical carcinoma: Additionally, for virally associated cancers, such as Human Papilloma Virus-induced anal and cervical cancer, PIs have been shown to target viral antigens that are necessary for viral replication, i.e. they have been observed to inhibit viral E6-mediated degradation of p53 [30].